American Journal of Epidemiology Vol. 133, No. 11: 1114-1124
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Human T-Lymphotropic Virus Type I (HTLV-I) Seroprevalence in Jamaica
I. Demographic Determinants
1Viral Epidemiology Section, National Cancer Institute Bethesda, MD
2Ministry of Health Kingston, Jamaica
3Department of Pathology, University of the West Indies Kingston, Jamaica
4Cornwall Regional Health Department Montego Bay Jamaica
5Atlantic Research Company Bethesda MD
6Biotech Research Laboratones Rockville, MD
Reprint requests to Dr Edward L Murphy, Department of Laboratory Medicine, University of Cairfomnia at San Francisco, Box 0884, San Francisco, CA 94143.
During 1985 and 1986, the authors measured antibodies to human T-lymphotropic virus type I (HTLV-I) in a cohort of 13,260 Jamaicans from all parts of the island who applied for food-handling licenses. HTLV-I seroprevalence was strongly age and sex dependent, rising from 1.7% (10–19 years) to 9.1%(
70 years) in men and from 1.9% (10–19 years) to 17.4– (70 years) in women. in a logistic regression analysis, women were more likely to be seropositive than were men, and farmers, laborers, and the unemployed were more likely to be HTLV-I seropositive than were those reporting student or professional occupations. In men, African ethnicity was associated with HTLV-I seropositivity in the univariate analysis but was not a risk factor after adjustment for age and sex. There was a trend toward higher age-stratified HTLV-I seroprevalence among younger women who reported more pregnancies, but older multigraviclas had lower rates of HTLV-I seropositivity. Persons born outside Jamaica had significantly lower seroprevalence than did those born in Jamaica, but they were of slightly different ethnic and occupational compositions than those born in Jamaica.
age factors; HTLV-I; HTLV-I antibodies; parity; sex factors; socioeconomic factors
7Current address: Departments of Laboratory Medicine, Medicine, and Epidemiology and Brostatistics, University of California, San Francisco, CA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Ali, G. Char, and B. Hanchard Chronic inflammatory demyelinating polyneuropathy in a patient infected with human T lymphotropic virus type I BMJ Case Reports, August 20, 2009; 2009(aug20_1): bcr0320091680 - bcr0320091680. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. B. Armah, E. G. Narter-Olaga, A. A. Adjei, K. Asomaning, R. K. Gyasi, and Y. Tettey Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana J. Med. Microbiol., June 1, 2006; 55(6): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. TORTEVOYE, P. TUPPIN, G. CARLES, C. PENEAU, and A. GESSAIN COMPARATIVE TRENDS OF SEROPREVALENCE AND SEROINCIDENCE RATES OF HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I AND HUMAN IMMUNODEFICIENCY VIRUS 1 IN PREGNANT WOMEN OF VARIOUS ETHNIC GROUPS SHARING THE SAME ENVIRONMENT IN FRENCH GUIANA Am J Trop Med Hyg, September 1, 2005; 73(3): 560 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. KASHIWAGI, N. FURUSYO, H. NAKASHIMA, N. KUBO, N. KINUKAWA, S. KASHIWAGI, and J. HAYASHI A DECREASE IN MOTHER-TO-CHILD TRANSMISSION OF HUMAN T LYMPHOTROPIC VIRUS TYPE I (HTLV-I) IN OKINAWA, JAPAN Am J Trop Med Hyg, February 1, 2004; 70(2): 158 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Z. Imirizaldu, J C G. Esteban, I R. Axpe, T P. Concha, F V. Juanes, I A. Susaeta, and J M C. Carranceja Post-transplantation HTLV-1 myelopathy in three recipients from a single donor J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1080 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. U. GONCALVES, A. C. M. GUEDES, A. B. DE FREITAS CARNEIRO PROIETTI, M. L. MARTINS, F. A. PROIETTI, and J. R. LAMBERTUCCI DERMATOLOGIC LESIONS IN ASYMPTOMATIC BLOOD DONORS SEROPOSITIVE FOR HUMAN T CELL LYMPHOTROPIC VIRUS TYPE-1 Am J Trop Med Hyg, May 1, 2003; 68(5): 562 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsukasaki, C. W. Miller, T. Kubota, S. Takeuchi, T. Fujimoto, S. Ikeda, M. Tomonaga, and H. P. Koeffler Tumor Necrosis Factor {{alpha}} Polymorphism Associated with Increased Susceptibility to Development of Adult T-Cell Leukemia/Lymphoma in Human T-lymphotropic Virus Type 1 Carriers Cancer Res., May 1, 2001; 61(9): 3770 - 3774. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Rouet, L. Meertens, G. Courouble, C. Herrmann-Storck, R. Pabingui, B. Chancerel, A. Abid, M. Strobel, P. Mauclere, and A. Gessain Serological, Epidemiological, and Molecular Differences between Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Seropositive Healthy Carriers and Persons with HTLV-I Gag Indeterminate Western Blot Patterns from the Caribbean J. Clin. Microbiol., April 1, 2001; 39(4): 1247 - 1253. [Abstract] [Full Text]
|
|
|
|
|
|
R. Mahieux, P. Horal, P. Mauclère, O. Mercereau-Puijalon, M. Guillotte, L. Meertens, E. Murphy, and A. Gessain Human T-Cell Lymphotropic Virus Type 1 Gag Indeterminate Western Blot Patterns in Central Africa: Relationship to Plasmodium falciparum Infection J. Clin. Microbiol., November 1, 2000; 38(11): 4049 - 4057. [Abstract] [Full Text]
|
|
|
|
 |
|
 A E Ades, S. Parker, J. Walker, M. Edginton, G. P Taylor, and J. N Weber Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study BMJ, June 3, 2000; 320(7248): 1497 - 1501. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. La Grenade, A. Manns, V. Fletcher, C. Carberry, B. Hanchard, E. M. Maloney, B. Cranston, N. P. Williams, R. Wilks, E. C. Kang, et al. Clinical, Pathologic, and Immunologic Features of Human T-Lymphotrophic Virus Type I-Associated Infective Dermatitis in Children Arch Dermatol, April 1, 1998; 134(4): 439 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gessain and O. Gout Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I) Ann Intern Med, December 1, 1992; 117(11): 933 - 946. [Abstract] [PDF]
|
|